NCT04425343

Brief Summary

The study was developed in compliance with the Helsinki Declaration on medical research involving the Ethics Committee at Ajman University (2017-A-DN-04). Informed consent from all the participants was obtained before participation in the study. The participants were systemically healthy with no history of antibiotics for the past three months. Patients recruited for the study were diagnosed as Stage II Generalized periodontitis according to the classification from the 2017 world workshop on the "classification of periodontal and peri-implant disease and conditions". Periodontal status indicating the severity of interdental clinical attachment loss of 3-4mm, radiographic bone loss between 15%-33% and with no tooth loss were included. The complexity of periodontitis with a maximum probing depth of ≤ 5mm with horizontal bone loss and having an extent and distribution with \>30% teeth involved were included in the study. A total of 80 plaque samples were collected with the clinical characteristics of the patient comprising of age between 25-39 years, 36 females and 44 males. The subgingival plaque was collected using a sterile curette from the buccal aspect of maxillary molars and lingual aspect of mandibular incisors, in a vial containing 200µl of Buffer CL.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 10, 2017

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2018

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 7, 2019

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

June 7, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 11, 2020

Completed
Last Updated

June 11, 2020

Status Verified

June 1, 2020

Enrollment Period

10 months

First QC Date

June 7, 2020

Last Update Submit

June 9, 2020

Conditions

Keywords

metagenomics16SPeriodontitis, Adult

Outcome Measures

Primary Outcomes (1)

  • Microbial Taxonomical Composition

    The composition was determined using subgingival plaque samples and performing 16s metagenomic sequencing

    From Baseline to 3 months

Study Arms (2)

Periodontitis, Adult

EXPERIMENTAL

Plaque samples were taken from subgingival pocket and send to the lab for metagenomic analysis

Genetic: 16s RNA Metagenomics sequencing

Metgenomic analysis

EXPERIMENTAL

Analysis for whole bacterial count

Genetic: 16s RNA Metagenomics sequencing

Interventions

The subgingival plaque was collected using a sterile curette from the buccal aspect of maxillary molars and lingual aspect of mandibular incisors, in a vial containing 200µl of Buffer CL.

Also known as: DNA isolation
Metgenomic analysisPeriodontitis, Adult

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients recruited for the study were diagnosed as Stage II Generalized periodontitis
  • Medically fit

You may not qualify if:

  • Patients having gingivitis or stage III periodontitis
  • Medically unfit

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ajman University of Science and Technology

Ajman, 009716, United Arab Emirates

Location

MeSH Terms

Conditions

Periodontal DiseasesChronic Periodontitis

Condition Hierarchy (Ancestors)

Mouth DiseasesStomatognathic DiseasesPeriodontitisChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Sudhir Varma, MDS

    Assistant Professor

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
. A total of 80 plaque samples were collected with the clinical characteristics of the patient comprising of age between 25-39 years, 36 females and 44 males
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Model Details: . Patients recruited for the study were diagnosed as Stage II Generalized periodontitis according to the classification from the 2017 world workshop on the "classification of periodontal and peri-implant disease and conditions". Periodontal status indicating the severity of interdental clinical attachment loss of 3-4mm, radiographic bone loss between 15%-33% and with no tooth loss were included. The complexity of periodontitis with a maximum probing depth of ≤ 5mm with horizontal bone loss and having an extent and distribution with \>30% teeth involved were included in the study.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

June 7, 2020

First Posted

June 11, 2020

Study Start

November 10, 2017

Primary Completion

September 15, 2018

Study Completion

October 7, 2019

Last Updated

June 11, 2020

Record last verified: 2020-06

Data Sharing

IPD Sharing
Will not share

Microbial Taxonomical Composition

Locations